Table 1.
The age, gender, post mortem interval (PMI) and diagnosis for the controls and cases used for immunofluorescence analyses.
| Case no. | Age (years) | Gender | PMI (h) | Diagnosis |
|---|---|---|---|---|
| Ct7 | 59 | Female | 30 | Control |
| Ct8 | 63.4 | Female | 30.5 | Control |
| Ct9 | 65.8 | Female | 43 | Control |
| Ct1 | 67.3 | Female | 24 | Control |
| Ct10 | 68.3 | Female | 71.5 | Control |
| Ct11 | 78.8 | Female | 19 | Control |
| Ct12 | 79 | Female | 32 | Control |
| Ct13 | 80.7 | Female | 59 | Control |
| Ct14 | 81.2 | Female | 25 | Control |
| Ct2 | 82.7 | Female | 28.5 | Control |
| AD7 | 62.5 | Female | 5.5 | AD |
| AD8 | 64.7 | Female | 21 | AD |
| AD9 | 65.9 | Female | 40 | AD |
| AD3 | 67.8 | Female | 21 | AD |
| AD10 | 68.4 | Female | 31 | AD |
| AD11 | 78.9 | Female | 19.5 | AD |
| AD12 | 79.9 | Female | 35 | AD |
| AD13 | 80.3 | Female | 62 | AD |
| AD14 | 82.5 | Female | 15.5 | AD |
| AD15 | 82.7 | Female | 8 | AD |